Podcast
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Hosted by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives · EN
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology.
Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com.
Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.
Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com.
Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.
35episodes
Episodes
Newest firstAll episodes
Diabetes Dialogue: Inequities & Barriers in Diabetes, with Jasmine Gonzalvo, PharmD
Jun 9, 2022Tap to summarizeIn the third special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, Dr. Jasmine Gonzalvo, director of the Center for Health Equity and Innovation at the Purdue University College of Pharmacy, joins hosts Drs. Diana Isaacs and Natalie Bellini to discuss prevailing barriers in diabetes management, including access to new pharmacologic agents as well as newer diabetes technologies.
Transcribe →
Diabetes Dialogue: Frontline Perspective from ADA 2022, with Gary Scheiner, MS, CDE
Jun 9, 2022Tap to summarizeIn our second special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, hosts Drs. Diana Isaacs and Natalie Bellini are joined by Gary Scheiner, MS, CDE. Clinical director of Integrated Diabetes Services, author of multiple books, and former Diabetes Educator of the Year, Scheiner joins Diabetes Dialogue to provide a deep dive into the largest diabetes meeting of the year from the view of a diabetes care and education specialist.
Transcribe →
Diabetes Dialogue: ATTD 2022 Recap
May 6, 2022Tap to summarizeIn this special edition ATTD Recap episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Natalie Bellini, DNP, FNP-BC, provide insight into their favorite sessions from the conference and clinical pearls they took away from their experience, including latest updates in the world of diabetes smart phone apps, smart insulin pens, and CGM systems. Also in the episode, our hosts react to Eli Lilly and Company’s announcement of topline data from the SURMOUNT-1 trial in late April.
Transcribe →
Diabetes Dialogue: April 2022
Apr 28, 2022Tap to summarizeIn the April 2022 edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini discuss the implications of semaglutide 2.0 mg (Ozempic)'s approval, the use of novel glycemic control metrics, and a preview of ATTD 2022.
Transcribe →
Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives
Mar 30, 2022Tap to summarizeThe inaugural episode of Diabetes Dialogue features an introduction to hosts Diana Isaacs, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Natalie Bellini, DNP, FNP-BC, and a discussion around recent regulatory news surrounding CGM devices in the US and Europe.
Transcribe →